Lifeward (NASDAQ:LFWD) Shares Down 4.6% – Here’s Why

Lifeward Ltd. (NASDAQ:LFWD)’s stock price was down 4.6% during trading on Monday . The stock traded as low as $7.55 and last traded at $7.55. Approximately 15,948 shares traded hands during trading, a decline of 10% from the average daily volume of 17,779 shares. The stock had previously closed at $7.91.

Analysts Set New Price Targets

Several research firms have issued reports on LFWD. Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a research note on Tuesday, April 21st. Zacks Research lowered shares of Lifeward from a “hold” rating to a “strong sell” rating in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Buy rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and an average price target of $10.00.

Lifeward Trading Down 4.6%

The firm has a fifty day simple moving average of $7.32 and a two-hundred day simple moving average of $7.06. The stock has a market cap of $21.22 million, a PE ratio of -0.38 and a beta of 0.37. The company has a current ratio of 2.40, a quick ratio of 1.82 and a debt-to-equity ratio of 1.16.

Lifeward (NASDAQ:LFWD) last issued its quarterly earnings results on Friday, May 15th. The company reported ($6.70) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.18) by ($5.52). Lifeward had a negative net margin of 123.66% and a negative return on equity of 243.14%. The business had revenue of $3.92 million for the quarter, compared to the consensus estimate of $5.78 million. As a group, equities analysts expect that Lifeward Ltd. will post -4.27 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Lifeward

Hedge funds have recently bought and sold shares of the stock. Jane Street Group LLC increased its holdings in shares of Lifeward by 77.3% in the 4th quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after buying an additional 29,927 shares during the last quarter. Citadel Advisors LLC raised its position in shares of Lifeward by 1,271.8% during the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after buying an additional 198,406 shares in the last quarter. Virtu Financial LLC lifted its holdings in shares of Lifeward by 158.0% during the 4th quarter. Virtu Financial LLC now owns 60,474 shares of the company’s stock worth $35,000 after acquiring an additional 37,037 shares during the last quarter. Finally, HRT Financial LP lifted its holdings in shares of Lifeward by 149.7% during the 4th quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after acquiring an additional 29,423 shares during the last quarter. 26.76% of the stock is currently owned by institutional investors.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.